Clinical Trial Update: Clinical Analgesic Management in Dementia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating analgesic management in Alzheimer's disease is currently recruiting, sponsored by Xuanwu Hospital, Beijing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Alzheimer Disease | Phase 3 | Status: RECRUITING